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The Los Angeles County Department of Public Health teamed
with a culturally tailored, community-based organization to aug-
ment their hepatitis B screening program with blood pressure as-
sessments. During 6 months, 2,298 people were served by the pro-
gram; descriptive statistics and models were generated to describe
demographics and screening and assessment results. Despite the
program having good reach, sustainability was challenging. This
experience  draws  attention  to  the  need  for  invested  desire  to
change at both the organizational and patient levels to sustain in-
terdisciplinary provision of clinical preventive services.
Objective
The Centers  for  Disease Control  and Prevention’s 2012 Com-
munity Transformation Grants (CTG) program sought to improve
health by addressing 3 strategic directions, including the ABCs of
prevention (aspirin use, blood pressure control, cholesterol man-
agement, and smoking cessation) (1).
As a CTG grantee, the Los Angeles County Department of Public
Health supported strategies aimed at enhancing clinical preventive
services. One such effort included extending services to hard-to-
reach Asians by partnering with a culturally tailored, community-
based organization to include blood pressure assessments in their
long-standing  hepatitis  B  screening  program.  This  report  de-
scribes this program and lessons learned.
Methods
Augmentation of the existing program began in August 2012. In
the ensuing 6 months, 2,298 people were offered screening for
hepatitis B surface antigen (HBsAg) and hepatitis B surface anti-
bodies (anti-HBs) at 26 community health events; at 18 events,
1,499 people were also offered blood pressure assessments. Blood
pressure assessments were not offered at 8 events because other
organizations were providing this service. Hepatitis testing was
administered by certified and licensed staff, and blood pressure
measurements were taken by trained volunteers using an auto-
mated sphygmomanometer. Events were held in primarily Asian
communities, but services were available to any person regardless
of race/ethnicity.  People interested in screening or assessment
were given educational information and asked to complete a self-
administered intake questionnaire, which included questions about
date of birth, sex, race/ethnicity, and marital status, in the appro-
priate language.
Hepatitis B results were mailed directly to participants and/or their
referring physician within 2 or 3 weeks of screening. Blood pres-
sure results were available immediately. Those who screened pos-
itive for hepatitis B or possible hypertension were referred to loc-
al clinics for follow-up, using standardized clinical protocols. Pro-
tocols for the case study were reviewed and approved by the Los
Angeles County Department of Public Health institutional review
board.
Descriptive statistics were generated to describe demographics and
screening and assessment results. Contingency tables of HBsAg
and anti-HBs results were created to stratify disease staging (2). A
multivariable logistic regression model, which included data on
2,013 participants, was constructed to describe factors associated
with a positive HBsAg test. A generalized ordered logit analysis
was performed to examine factors that influenced blood pressure
results; of those who received assessments, 1,178 had complete
data and were included in the model. Because the proportional
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health
and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.
www.cdc.gov/pcd/issues/2015/14_0373.htm • Centers for Disease Control and Prevention      1
odds assumption was not met for all variables in the ordered mod-
el, the less restrictive, user-written “gologit2” program was used
(3). All data analyses were conducted using Stata, version 12.0
(StataCorp LP).
Results
Most program participants (61.2%, n = 1,407) were women. More
than half (n = 1,385) were aged 45 to 64 years, and most were
married (62.5%, n = 1,437) (Table 1).
Of those screened (n = 2,232), 159 participants tested positive for
HBsAg; 1,458 tested positive for anti-HBs (Table 1); 1,445 parti-
cipants were immune and 628 (who had no immunity) were eli-
gible for vaccination. Tests suggested that 146 participants had an
active chronic infection that would possibly require life-long fol-
low-up and treatment (5).
Of the 1,499 participants who were offered blood pressure assess-
ments, 1,318 had their measurements taken. Of these, 34.6% had
readings in the prehypertension range; 28.8% had readings in the
hypertension range (Table 1). Forty-two of these latter cases were
also HBsAg positive.
In the regression analysis of HBsAg results (n = 2,013), race/eth-
nicity was associated with a positive test (Table 2). When strati-
fied by race/ethnicity, “other Asian” and “other” groups were less
likely than Southeast Asians to test positive for HBsAg (P < .05).
Those aged 65 or older also were less likely than those aged 44 or
younger to test positive (adjusted odds ratio [AOR] = 0.52; 95%
confidence interval  [CI],  0.28–0.96; P = .03).  Men were more
likely  than  women  to  test  positive  (AOR  =  1.67;  95%  CI,
1.19–2.36; P = .003).
No significant association was found between race/ethnicity or
marriage status and blood pressure readings. However, men and
participants aged 65 or older (compared with those aged ≤44) were
more likely to have blood pressure readings in the prehyperten-
sion and hypertension ranges (P ≤ .001) (Table 2).
Discussion
The integration of blood pressure assessments to an existing hepat-
itis  B screening program reached a  good number  of  high-risk
people  during  the  6-month  study  period.  About  7%  of  those
screened for hepatitis B were thought to have active chronic infec-
tion; however, disease severity, including the degree of portal hy-
pertension and liver cirrhosis, was not assessed in this study. An-
other 28% had no immunity and could benefit from vaccination.
Almost two-thirds of those assessed for blood pressure had read-
ings in the prehypertension or hypertension ranges. A subgroup
analysis suggested that treatment was not uniform. For example,
of 42 Chinese adults with readings in the hypertension range, only
22 reported taking blood pressure medications. These and other
results from the models were consistent with the literature, further
highlighting the risks associated with these conditions (4,6,7).
Building on a well-established community-based effort enabled
the Los Angeles County Department of Health to engage a high-
risk segment of the Asian community that has limited access to
and limited use of high-quality medical care because of socioeco-
nomic constraints, language barriers, and cultural beliefs (8). Des-
pite the benefits of this augmented program, sustainability was a
challenge. Program infrastructure made field implementation of
blood pressure screening relatively simple and efficient; however,
challenges arose when participants were reluctant to lengthen their
encounter time to receive the additional services. To maintain cli-
ent satisfaction and participation in the hepatitis B screening, the
blood pressure assessments were discontinued. This experience
draws attention to the need for an invested desire for change at
both the organizational and patient levels. A shift in this social
norm is essential for sustaining interdisciplinary provision of clin-
ical preventive services.
This enhanced program underscores the value of bringing togeth-
er multiple partners (eg, health care, public health, the community)
to leverage resources and develop community–clinical linkages.
For this model of practice to be sustainable, coordination of in-
vestments, services, and innovation in the community should be
strengthened. Furthermore, a shift in the collective attitude toward
supporting these and other prevention efforts is needed.
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Tables
Table 1. Characteristics of Participants in a Hepatitis B Screening and Blood Pressure Assessment Program in Los
Angeles County, 2012–2013a
Demographics and Screening and
Assessment Results
All Participants (N =
2,298)
Participants Screened for
Hepatitis B (n = 2,232)
Participants Assessed for High
Blood Pressure (n = 1,318)
Age, y
<18 23 (1.0) 22 (1.0) 0
18–44 444 (19.3) 430 (19.3) 240 (18.2)
45–64 1,385 (60.3) 1,344 (60.2) 787 (59.7)
65–74 327 (14.2) 320 (14.3) 215 (16.3)
75–84 106 (4.6) 103 (4.6) 70 (5.3)
≥85 13 (0.6) 13 (0.6) 6 (0.5)
Sex
Female 1,407 (61.2) 1,357 (60.8) 811 (61.5)
Male 889 (38.7) 874 (39.2) 507 (38.5)
Race/ethnicityb
Southeast Asian 1,034 (45.0) 1,004 (45.0) 742 (56.3)
Chinese/Taiwanese 737 (32.1) 726 (32.5) 370 (28.1)
Other Asian 255 (11.1) 246 (11.0) 34 (2.6)
Other 162 (7.0) 149 (6.7) 99 (7.5)
Marital status
Single or widowed 685 (29.8) 660 (29.6) 419 (31.8)
Married 1,437 (62.5) 1,402 (62.8) 792 (60.1)
Hepatitis B results
  HBsAg
  Positive  — 159 (7.1)  —
  Negative  — 2,073 (92.9)  —
  Anti-HBs
  Positive  — 1,458 (65.3)  —
  Negative  — 774 (34.7)  —
Blood pressure readingsc
Normal  —  — 483 (36.7)
Prehypertension  —  — 456 (34.6)
Stage 1 hypertension  —  — 284 (21.6)
Abbreviations: —, not applicable; HBsAg, hepatitis B surface antigen; anti-HBs, hepatitis B surface antibodies.
a All values are numbers and percentages; they may not add to 100% because of missing values or rounding.
b Southeast Asian includes Burmese, Cambodian, Filipino, Laotian, Thai, and Vietnamese; “other Asian” includes Armenian, Bangladeshi, Indian, Japan-
ese, Korean, Lebanese, and Mongolian; “other” includes African American, white, Hispanic, Native American, Ukrainian, and multiracial people.
c Hypertension classification as defined by the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of
High Blood Pressure (4).
(continued on next page)
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(continued)
Table 1. Characteristics of Participants in a Hepatitis B Screening and Blood Pressure Assessment Program in Los
Angeles County, 2012–2013a
Demographics and Screening and
Assessment Results
All Participants (N =
2,298)
Participants Screened for
Hepatitis B (n = 2,232)
Participants Assessed for High
Blood Pressure (n = 1,318)
Stage 2 hypertension  —  — 95 (7.2)
Abbreviations: —, not applicable; HBsAg, hepatitis B surface antigen; anti-HBs, hepatitis B surface antibodies.
a All values are numbers and percentages; they may not add to 100% because of missing values or rounding.
b Southeast Asian includes Burmese, Cambodian, Filipino, Laotian, Thai, and Vietnamese; “other Asian” includes Armenian, Bangladeshi, Indian, Japan-
ese, Korean, Lebanese, and Mongolian; “other” includes African American, white, Hispanic, Native American, Ukrainian, and multiracial people.
c Hypertension classification as defined by the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of
High Blood Pressure (4).
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Table 2. Factors Associated With Positive Screening Results Among Participants in a Hepatitis B Screening and Blood
Pressure Assessment Program, Los Angeles County, 2012–2013
Independent variable
HBsAg Positive, AOR
(95% CI) (N = 2,013)a
Normal vs Prehypertension and
Hypertensionb Coefficient (95% CI) (n
= 1,178)c
Normal and Prehypertension vs
Hypertensionb Coefficient (95% CI) (n
= 1,178)c
Race/ethnicityd
Chinese/Taiwanese 0.90 (0.63 to 1.30) −0.11 (−0.36 to 0.14) −0.11 (−0.36 to 0.14)
Other Asian 0.32e (0.15 to 0.71) 0.48 (−0.20 to 1.16) 0.48 (−0.20 to 1.16)
Other 0.23f (0.07 to 0.74) −0.21 (−0.63 to 0.20) −0.21 (−0.63 to 0.20)
Southeast Asian 1.0 [Reference] 1.0 [Reference] 1.0 [Reference]
Age, y
45–64 1.04 (0.67 to 1.60) 0.90g (0.60 to 1.21) 0.90g (0.60 to 1.21)
≥65 0.52h (0.28 to 0.96) 1.83g (1.40 to 2.25) 1.07g (0.67 to 1.47)
≤44 1.0 [Reference] 1.0 [Reference] 1.0 [Reference]
Sex
Male 1.67i (1.19 to 2.36) 0.76g (0.49 to 1.02) 0.44g (0.18 to 0.70)
Female 1.0 [Reference] 1.0 [Reference] 1.0 [Reference]
Marital status
Married 1.16 (0.79 to 1.70) −0.10 (−0.34 to 0.13) −0.10 (−0.34 to 0.13)
Single or widowed 1.0 [Reference] 1.0 [Reference] 1.0 [Reference]
Abbreviations: AOR, adjusted odds ratio; CI, confidence interval; HBsAg, hepatitis B surface antigen.
a Logistic regression model.
b Hypertension classification as defined by the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of
High Blood Pressure (4).
c Generalized ordered logit model.
d Southeast Asian includes Burmese, Cambodian, Filipino, Laotian, Thai, and Vietnamese; “other Asian” includes Armenian, Bangladeshi, Indian, Japan-
ese, Korean, Lebanese, and Mongolian; “other” includes African American, white, Hispanic, Native American, Ukrainian, and multiracial people.
e P = .005.
f P = .01.
g P ≤ .001.
h P = .03.
i P = .003.
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